HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients.

Abstract
Serum samples from patients with connective tissue disease (CTD) were characterized using a recently developed enzyme-linked immunosorbent assay for reactivity with individual specific polypeptides of U1 small nuclear ribonucleoproteins, including the U1-70-kd protein. The distribution of HLA antigens was compared in CTD patients with and in those without anti-U1-70-kd autoantibodies and in normal controls. The frequencies of HLA-DR4 and HLA-DRw53 were increased among the anti-U1-70-kd autoantibody positive CTD group compared with the frequencies in anti-U1-70-kd autoantibody negative systemic lupus erythematosus patients and compared with normal controls. We conclude that the presence of autoantibodies reactive with the anti-U1-70-kd protein antigen is associated with HLA-DR4 and HLA-DRw53.
AuthorsR W Hoffman, L J Rettenmaier, Y Takeda, J E Hewett, I Pettersson, U Nyman, A M Luger, G C Sharp
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 33 Issue 5 Pg. 666-73 (May 1990) ISSN: 0004-3591 [Print] United States
PMID2140681 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Antinuclear
  • Autoantibodies
  • HLA-DQ Antigens
  • HLA-DR Antigens
  • HLA-DR4 Antigen
  • Ribonucleoproteins
  • Ribonucleoproteins, Small Nuclear
Topics
  • Antibodies, Antinuclear (analysis)
  • Autoantibodies (analysis)
  • Connective Tissue Diseases (immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HLA-DQ Antigens (analysis)
  • HLA-DR Antigens (analysis)
  • HLA-DR4 Antigen (analysis)
  • Humans
  • Male
  • Phenotype
  • Ribonucleoproteins (immunology)
  • Ribonucleoproteins, Small Nuclear

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: